2024-12-012025-11-302025-11-30false10465350ULTIMATE CARE AGENCY LIMITED2026-09-01falseiso4217:GBPxbrli:pure104653502024-11-30104653502025-11-30104653502024-12-012025-11-30104653502023-11-30104653502024-11-30104653502023-12-012024-11-3010465350bus:SmallEntities2024-12-012025-11-3010465350bus:AuditExempt-NoAccountantsReport2024-12-012025-11-3010465350bus:AbridgedAccounts2024-12-012025-11-3010465350bus:PrivateLimitedCompanyLtd2024-12-012025-11-3010465350core:WithinOneYear2025-11-3010465350core:AfterOneYear2025-11-3010465350core:WithinOneYear2024-11-3010465350core:AfterOneYear2024-11-3010465350core:ShareCapital2025-11-3010465350core:SharePremium2025-11-3010465350core:RevaluationReserve2025-11-3010465350core:OtherReservesSubtotal2025-11-3010465350core:RetainedEarningsAccumulatedLosses2025-11-3010465350core:ShareCapital2024-11-3010465350core:SharePremium2024-11-3010465350core:RevaluationReserve2024-11-3010465350core:OtherReservesSubtotal2024-11-3010465350core:RetainedEarningsAccumulatedLosses2024-11-3010465350core:LandBuildings2025-11-3010465350core:PlantMachinery2025-11-3010465350core:Vehicles2025-11-3010465350core:FurnitureFittings2025-11-3010465350core:OfficeEquipment2025-11-3010465350core:NetGoodwill2025-11-3010465350core:IntangibleAssetsOtherThanGoodwill2025-11-3010465350core:ListedExchangeTraded2025-11-3010465350core:UnlistedNon-exchangeTraded2025-11-3010465350core:LandBuildings2024-11-3010465350core:PlantMachinery2024-11-3010465350core:Vehicles2024-11-3010465350core:FurnitureFittings2024-11-3010465350core:OfficeEquipment2024-11-3010465350core:NetGoodwill2024-11-3010465350core:IntangibleAssetsOtherThanGoodwill2024-11-3010465350core:ListedExchangeTraded2024-11-3010465350core:UnlistedNon-exchangeTraded2024-11-3010465350core:LandBuildings2024-12-012025-11-3010465350core:PlantMachinery2024-12-012025-11-3010465350core:Vehicles2024-12-012025-11-3010465350core:FurnitureFittings2024-12-012025-11-3010465350core:OfficeEquipment2024-12-012025-11-3010465350core:NetGoodwill2024-12-012025-11-3010465350core:IntangibleAssetsOtherThanGoodwill2024-12-012025-11-3010465350core:ListedExchangeTraded2024-12-012025-11-3010465350core:UnlistedNon-exchangeTraded2024-12-012025-11-3010465350core:MoreThanFiveYears2024-12-012025-11-3010465350core:Non-currentFinancialInstruments2025-11-3010465350core:Non-currentFinancialInstruments2024-11-3010465350dpl:CostSales2024-12-012025-11-3010465350dpl:DistributionCosts2024-12-012025-11-3010465350core:LandBuildings2024-12-012025-11-3010465350core:PlantMachinery2024-12-012025-11-3010465350core:Vehicles2024-12-012025-11-3010465350core:FurnitureFittings2024-12-012025-11-3010465350core:OfficeEquipment2024-12-012025-11-3010465350dpl:AdministrativeExpenses2024-12-012025-11-3010465350core:NetGoodwill2024-12-012025-11-3010465350core:IntangibleAssetsOtherThanGoodwill2024-12-012025-11-3010465350dpl:GroupUndertakings2024-12-012025-11-3010465350dpl:ParticipatingInterests2024-12-012025-11-3010465350dpl:GroupUndertakingscore:ListedExchangeTraded2024-12-012025-11-3010465350core:ListedExchangeTraded2024-12-012025-11-3010465350dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-12-012025-11-3010465350core:UnlistedNon-exchangeTraded2024-12-012025-11-3010465350dpl:CostSales2023-12-012024-11-3010465350dpl:DistributionCosts2023-12-012024-11-3010465350core:LandBuildings2023-12-012024-11-3010465350core:PlantMachinery2023-12-012024-11-3010465350core:Vehicles2023-12-012024-11-3010465350core:FurnitureFittings2023-12-012024-11-3010465350core:OfficeEquipment2023-12-012024-11-3010465350dpl:AdministrativeExpenses2023-12-012024-11-3010465350core:NetGoodwill2023-12-012024-11-3010465350core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3010465350dpl:GroupUndertakings2023-12-012024-11-3010465350dpl:ParticipatingInterests2023-12-012024-11-3010465350dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-012024-11-3010465350core:ListedExchangeTraded2023-12-012024-11-3010465350dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-012024-11-3010465350core:UnlistedNon-exchangeTraded2023-12-012024-11-3010465350core:NetGoodwill2025-11-3010465350core:IntangibleAssetsOtherThanGoodwill2025-11-3010465350core:LandBuildings2025-11-3010465350core:PlantMachinery2025-11-3010465350core:Vehicles2025-11-3010465350core:FurnitureFittings2025-11-3010465350core:OfficeEquipment2025-11-3010465350core:AfterOneYear2025-11-3010465350core:WithinOneYear2025-11-3010465350core:ListedExchangeTraded2025-11-3010465350core:UnlistedNon-exchangeTraded2025-11-3010465350core:ShareCapital2025-11-3010465350core:SharePremium2025-11-3010465350core:RevaluationReserve2025-11-3010465350core:OtherReservesSubtotal2025-11-3010465350core:RetainedEarningsAccumulatedLosses2025-11-3010465350core:NetGoodwill2024-11-3010465350core:IntangibleAssetsOtherThanGoodwill2024-11-3010465350core:LandBuildings2024-11-3010465350core:PlantMachinery2024-11-3010465350core:Vehicles2024-11-3010465350core:FurnitureFittings2024-11-3010465350core:OfficeEquipment2024-11-3010465350core:AfterOneYear2024-11-3010465350core:WithinOneYear2024-11-3010465350core:ListedExchangeTraded2024-11-3010465350core:UnlistedNon-exchangeTraded2024-11-3010465350core:ShareCapital2024-11-3010465350core:SharePremium2024-11-3010465350core:RevaluationReserve2024-11-3010465350core:OtherReservesSubtotal2024-11-3010465350core:RetainedEarningsAccumulatedLosses2024-11-3010465350core:NetGoodwill2023-11-3010465350core:IntangibleAssetsOtherThanGoodwill2023-11-3010465350core:LandBuildings2023-11-3010465350core:PlantMachinery2023-11-3010465350core:Vehicles2023-11-3010465350core:FurnitureFittings2023-11-3010465350core:OfficeEquipment2023-11-3010465350core:AfterOneYear2023-11-3010465350core:WithinOneYear2023-11-3010465350core:ListedExchangeTraded2023-11-3010465350core:UnlistedNon-exchangeTraded2023-11-3010465350core:ShareCapital2023-11-3010465350core:SharePremium2023-11-3010465350core:RevaluationReserve2023-11-3010465350core:OtherReservesSubtotal2023-11-3010465350core:RetainedEarningsAccumulatedLosses2023-11-3010465350core:AfterOneYear2024-12-012025-11-3010465350core:WithinOneYear2024-12-012025-11-3010465350core:Non-currentFinancialInstrumentscore:CostValuation2024-12-012025-11-3010465350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-012025-11-3010465350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-012025-11-3010465350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-012025-11-3010465350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-012025-11-3010465350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-012025-11-3010465350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3010465350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3010465350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3010465350core:Non-currentFinancialInstrumentscore:CostValuation2025-11-3010465350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-11-3010465350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-11-3010465350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-11-3010465350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-11-3010465350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-11-3010465350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-11-3010465350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-11-3010465350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-11-3010465350core:Non-currentFinancialInstrumentscore:CostValuation2024-11-3010465350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-3010465350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-3010465350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-3010465350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-3010465350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-3010465350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-3010465350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-3010465350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-3010465350bus:Director12024-12-012025-11-3010465350bus:Director22024-12-012025-11-30

ULTIMATE CARE AGENCY LIMITED

Registered Number
10465350
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2025

ULTIMATE CARE AGENCY LIMITED
Company Information
for the year from 1 December 2024 to 30 November 2025

Directors

Bosede Oluyinka Adeniran
Comfort Adetokunbo Adeniran

Registered Address

Unit 217 219 Somers Road North
Portsmouth
PO1 1PJ

Registered Number

10465350 (England and Wales)
ULTIMATE CARE AGENCY LIMITED
Balance Sheet as at
30 November 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets359,97074,963
59,97074,963
Current assets
Stocks415,62512,788
Debtors570,85947,538
Cash at bank and on hand52,99021,419
139,47481,745
Creditors amounts falling due within one year6(49,253)(18,931)
Net current assets (liabilities)90,22162,814
Total assets less current liabilities150,191137,777
Creditors amounts falling due after one year(48,256)(59,361)
Net assets101,93578,416
Capital and reserves
Called up share capital7575
Profit and loss account101,86078,341
Shareholders' funds101,93578,416
The financial statements were approved and authorised for issue by the Board of Directors on 1 September 2026, and are signed on its behalf by:
Bosede Oluyinka Adeniran
Director
Registered Company No. 10465350
ULTIMATE CARE AGENCY LIMITED
Notes to the Financial Statements
for the year ended 30 November 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings20
Vehicles20
Office Equipment20
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year3925
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 December 24104,032
At 30 November 25104,032
Depreciation and impairment
At 01 December 2429,069
Charge for year14,993
At 30 November 2544,061
Net book value
At 30 November 2559,970
At 30 November 2474,963
4.Stocks

2025

2024

££
Work in progress15,62512,788
Total15,62512,788
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables70,75947,438
Other debtors100100
Total70,85947,538
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables8,320-
Taxation and social security9,4464,838
Finance lease and HP contracts9,8569,856
Other creditors18,1001,924
Accrued liabilities and deferred income3,5312,313
Total49,25318,931
7.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts58,11169,217